GLAUKOS Corp Payments to Acquire Marketable Securities
GLAUKOS Corp (GKOS) reported Payments to Acquire Marketable Securities of $66.85 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-07-29
- GLAUKOS Corp payments to acquire marketable securities for the quarter ending 2026-06-30 was $35.49M, a 15.53% decline year-over-year.
- GLAUKOS Corp payments to acquire marketable securities for the quarter ending 2026-03-31 was $31.35M, a 58.05% decline year-over-year.
- GLAUKOS Corp payments to acquire marketable securities for the quarter ending 2025-12-31 was $40.16M, a 39.94% decline year-over-year.
- GLAUKOS Corp payments to acquire marketable securities for the quarter ending 2025-09-30 was $75.37M, a 135.50% increase year-over-year.
- GLAUKOS Corp payments to acquire marketable securities for fiscal 2025 was $232.29M, a 22.29% increase from fiscal 2024.
- GLAUKOS Corp payments to acquire marketable securities for fiscal 2024 was $189.96M, a 28.48% decline from fiscal 2023.
- GLAUKOS Corp payments to acquire marketable securities for fiscal 2023 was $265.59M, a 348.20% increase from fiscal 2022.
- GLAUKOS Corp payments to acquire marketable securities for fiscal 2022 was $59.26M, a 72.48% decline from fiscal 2021.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 3 month as first filed | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 6 month as first filed | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 9 month as first filed | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $35.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $66.85M 10-Q · filed 2026-07-29 | $107.01M derived: sum of 3 quarters · filed 2026-07-29 | $182.37M derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2026-03-31 | $31.35M 10-Q · filed 2026-04-30 | $71.51M derived: sum of 2 quarters · filed 2026-04-30 | $146.88M derived: sum of 3 quarters · filed 2026-04-30 | $188.90M derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2025-12-31 | $40.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $115.53M derived: sum of 2 quarters · filed 2026-02-23 | $157.55M derived: sum of 3 quarters · filed 2026-07-29 | $232.29M 10-K · filed 2026-02-23 | |||
| 2025-09-30 | $75.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $117.39M derived: sum of 2 quarters · filed 2026-07-29 | $192.13M 10-Q · filed 2025-10-31 | $259.00M derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2025-06-30 | $42.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $116.77M 10-Q · filed 2026-07-29 | $183.63M derived: sum of 3 quarters · filed 2026-07-29 | $215.63M derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2025-03-31 | $74.74M 10-Q · filed 2026-04-30 | $141.61M derived: sum of 2 quarters · filed 2026-04-30 | $173.61M derived: sum of 3 quarters · filed 2026-04-30 | $215.45M derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2024-12-31 | $66.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $98.87M derived: sum of 2 quarters · filed 2026-02-23 | $140.71M derived: sum of 3 quarters · filed 2026-02-23 | $189.96M 10-K · filed 2026-02-23 | |||
| 2024-09-30 | $32.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $73.84M derived: sum of 2 quarters · filed 2025-10-31 | $123.09M 10-Q · filed 2025-10-31 | $195.14M derived: sum of 4 quarters · filed 2026-02-23 | |||
| 2024-06-30 | $41.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $91.09M 10-Q · filed 2025-08-04 | $163.14M derived: sum of 3 quarters · filed 2026-02-23 | $186.61M derived: sum of 4 quarters · filed 2026-02-23 | |||
| 2024-03-31 | $49.25M 10-Q · filed 2025-05-01 | $121.30M derived: sum of 2 quarters · filed 2026-02-23 | $144.77M derived: sum of 3 quarters · filed 2026-02-23 | $218.54M derived: sum of 4 quarters · filed 2026-02-23 | |||
| 2023-12-31 | $72.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $95.52M derived: sum of 2 quarters · filed 2026-02-23 | $169.29M derived: sum of 3 quarters · filed 2026-02-23 | $265.59M 10-K · filed 2026-02-23 | |||
| 2023-09-30 | $23.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $97.24M derived: sum of 2 quarters · filed 2024-11-05 | $193.54M 10-Q · filed 2024-11-05 | $205.54M derived: sum of 4 quarters · filed 2025-02-25 | |||
| 2023-06-30 | $73.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $170.07M 10-Q · filed 2024-08-02 | $182.07M derived: sum of 3 quarters · filed 2025-02-25 | $192.39M derived: sum of 4 quarters · filed 2025-02-25 | |||
| 2023-03-31 | $96.30M 10-Q · filed 2024-05-03 | $108.30M derived: sum of 2 quarters · filed 2025-02-25 | $118.61M derived: sum of 3 quarters · filed 2025-02-25 | $138.80M derived: sum of 4 quarters · filed 2025-02-25 | |||
| 2022-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $22.32M derived: sum of 2 quarters · filed 2025-02-25 | $42.51M derived: sum of 3 quarters · filed 2025-02-25 | $59.26M 10-K · filed 2025-02-25 | |||
| 2022-09-30 | $10.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $30.51M derived: sum of 2 quarters · filed 2023-11-01 | $47.26M 10-Q · filed 2023-11-01 | $70.78M derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2022-06-30 | $20.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $36.94M 10-Q · filed 2023-08-02 | $60.47M derived: sum of 3 quarters · filed 2024-02-23 | $154.99M derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2022-03-31 | $16.75M 10-Q · filed 2023-05-04 | $40.28M derived: sum of 2 quarters · filed 2024-02-23 | $134.80M derived: sum of 3 quarters · filed 2024-02-23 | $178.03M derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2021-12-31 | $23.53M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $118.05M derived: sum of 2 quarters · filed 2024-02-23 | $161.28M derived: sum of 3 quarters · filed 2024-02-23 | $215.28M 10-K · filed 2024-02-23 | |||
| 2021-09-30 | $94.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $137.75M derived: sum of 2 quarters · filed 2022-11-04 | $191.76M 10-Q · filed 2022-11-04 | $218.96M derived: sum of 4 quarters · filed 2023-02-24 | |||
| 2021-06-30 | $43.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $97.23M 10-Q · filed 2022-08-05 | $124.44M derived: sum of 3 quarters · filed 2023-02-24 | $337.35M derived: sum of 4 quarters · filed 2023-02-24 | |||
| 2021-03-31 | $54.01M 10-Q · filed 2022-05-05 | $81.21M derived: sum of 2 quarters · filed 2023-02-24 | $294.13M derived: sum of 3 quarters · filed 2023-02-24 | $336.33M derived: sum of 4 quarters · filed 2023-02-24 | |||
| 2020-12-31 | $27.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $240.12M derived: sum of 2 quarters · filed 2023-02-24 | $282.32M derived: sum of 3 quarters · filed 2023-02-24 | $301.00M 10-K · filed 2023-02-24 | |||
| 2020-09-30 | $212.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $255.12M derived: sum of 2 quarters · filed 2021-11-08 | $273.80M 10-Q · filed 2021-11-08 | $290.63M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-06-30 | $42.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $60.88M 10-Q · filed 2021-08-05 | $77.72M derived: sum of 3 quarters · filed 2022-02-28 | $101.38M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | $18.68M 10-Q · filed 2021-05-06 | $35.51M derived: sum of 2 quarters · filed 2022-02-28 | $59.17M derived: sum of 3 quarters · filed 2022-02-28 | $82.45M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $16.83M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $40.49M derived: sum of 2 quarters · filed 2022-02-28 | $63.77M derived: sum of 3 quarters · filed 2022-02-28 | $80.39M 10-K · filed 2022-02-28 | |||
| 2019-09-30 | $23.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $46.94M derived: sum of 2 quarters · filed 2020-11-05 | $63.56M 10-Q · filed 2020-11-05 | $64.73M 10-Q · filed 2019-11-06 | $87.15M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-30 | $23.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $39.90M 10-Q · filed 2020-08-07 | $40.86M 10-Q · filed 2019-08-08 | $63.49M derived: sum of 3 quarters · filed 2021-03-01 | $86.46M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-31 | $16.61M 10-Q · filed 2020-05-07 | $40.21M derived: sum of 2 quarters · filed 2021-03-01 | $63.18M derived: sum of 3 quarters · filed 2021-03-01 | $82.39M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2018-12-31 | $23.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $46.56M derived: sum of 2 quarters · filed 2021-03-01 | $65.78M derived: sum of 3 quarters · filed 2021-03-01 | $93.70M 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $22.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $42.18M derived: sum of 2 quarters · filed 2019-11-06 | $70.10M 10-Q · filed 2019-11-06 | $92.97M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-06-30 | $19.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $47.13M 10-Q · filed 2019-08-08 | $70.00M derived: sum of 3 quarters · filed 2020-03-02 | $95.67M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-03-31 | $27.92M 10-Q · filed 2019-05-08 | $50.79M derived: sum of 2 quarters · filed 2020-03-02 | $76.46M derived: sum of 3 quarters · filed 2020-03-02 | $95.63M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2017-12-31 | $22.87M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $48.54M derived: sum of 2 quarters · filed 2020-03-02 | $67.71M derived: sum of 3 quarters · filed 2020-03-02 | $94.31M 10-K · filed 2020-03-02 | |||
| 2017-09-30 | $25.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $44.84M derived: sum of 2 quarters · filed 2018-11-07 | $71.44M 10-Q · filed 2018-11-07 | $85.91M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-06-30 | $19.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $45.77M 10-Q · filed 2018-08-06 | $60.23M derived: sum of 3 quarters · filed 2019-02-28 | $85.13M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-03-31 | $26.60M 10-Q · filed 2018-05-09 | $41.07M derived: sum of 2 quarters · filed 2019-02-28 | $65.97M derived: sum of 3 quarters · filed 2019-02-28 | $78.08M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2016-12-31 | $14.47M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $39.37M derived: sum of 2 quarters · filed 2019-02-28 | $51.48M derived: sum of 3 quarters · filed 2019-02-28 | $75.19M 10-K · filed 2019-02-28 | |||
| 2016-09-30 | $24.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $37.01M derived: sum of 2 quarters · filed 2017-11-08 | $60.72M 10-Q · filed 2017-11-08 | ||||
| 2016-06-30 | $12.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $35.83M 10-Q · filed 2017-08-07 | |||||
| 2016-03-31 | $23.71M 10-Q · filed 2017-05-04 | $377.00K 10-Q · filed 2016-05-04 | |||||
| 2015-12-31 | $69.75M 10-K · filed 2018-02-28 | ||||||
| 2015-03-31 | $215.00K 10-Q · filed 2016-05-04 | ||||||
| 2013-12-31 | $10.82M 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |